A ‘cost of inaction’ study released today unequivocally demonstrates to world leaders the economic consequences of failing to scale up global funding for AIDS, TB, and malaria.
Data shows that the world can save millions of lives and more than $USD 67 billion through scaled up investments in the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund has calculated that $USD 15 billion USD is needed over the next three years to maintain its successful programs, scale up proven interventions, and fund new programs that will ultimately bring these three global pandemics under control.
“We have reached a tipping point and now have the opportunity to end three of the biggest killers on our planet,” said Kolleen Bouchane, ACTION Director. “TB alone has been around for more than 70,000 years. Now it’s a question of what side of history our generation wants to be on.”
A $15 billion Global Fund Replenishment is essential to:
- Avert 3.9 million new HIV infections from 2014-2016, saving $USD 47 billion in treatment costs.
- Save 196,000 lives from malaria, and prevent 430 million new cases of malaria, saving $USD 20 billion GDP.
- Treat 3 million more people for TB and drug-resistant TB, helping to prevent the spread of drug-resistant TB, which can cost up to 1,000 times more to treat.
Progress against these three diseases in our lifetime has already been remarkable. In the case of TB, mortality rates worldwide declined by 41 percent from 1990 to 2011 – that means about 35 million people were successfully treated and 15 million lives were saved. As the world’s largest financer of the fight against TB, these gains would never have been possible without the Global Fund.
Now we are at a critical moment. If we don’t act now, our tremendous progress could fall backwards as urgent threats like drug resistance gain momentum. We have the knowledge and tools to end these diseases – now we need political will. At the fourth Global Fund Replenishment in December, ACTION and its partners urge all world leaders to come together with additional investments to ensure we collectively create this lifesaving legacy.
The full report can be read in full at http://icssupport.org/. It was developed by Dutch NGO International Civil Society Support (ICSS) to support the Global Fund Advocates Network, in consultation with the Global Fund Secretariat and its technical partners (UNAIDS, the STOP TB partnership and the Roll Back Malaria partnership